Architecting the future of predictive genomics – a blueprint for technology
This blog is the third in a series from Zetta Genomics CEO, Mark Bailley, on the opportunities of predictive medicine. Parts one and two looked at health systems and economies, and public education. Part three turns to the challenges of technology. Genomics has the potential to deliver predictive medicine that democratises healthcare, creates viable health […]
Architecting the future of predictive genomics: a blueprint for education
This blog is the second installment in a new series from Zetta Genomics CEO, Mark Bailley, on the opportunities of predictive genomics – and the challenges we need to overcome to realise them. Catch up on Part One of the blog series here.
Architecting the future of predictive genomics – a blueprint for health economies and systems
This blog is one in a new series from Zetta Genomics CEO, Mark Bailley, on the opportunities of predictive genomics – and the challenges we need to overcome to realise them. We are in a golden age of medical discovery. As research accelerates, we are seeing an explosion in novel drugs, treatments and therapies. Technology […]
Four key challenges to address when building a genome-optimised analysis platform
Over the past ten years, there has been explosive growth in the sheer quantity of human genomic data. The first human genome was sequenced in 2003, following more than a decade of international scientific cooperation and a total cost of over $3 billion. By 2010 over a thousand genomes had been sequenced (thanks in no […]
The University of Edinburgh acts as an exemplar to explore the potential of genomic data management technologies
Alison Meynert is Senior Research Fellow and Bioinformatics Analysis Core Manager at the MRC Human Genetics Unit – part of the Institute of Genetics and Cancer – at the University of Edinburgh. Alison talks with Zetta Genomics’ Stuart Jenks about the rollout of XetaBase to the EIDF Variant Repository Pilot Project – and its potential […]
From one genome to millions: data technology to unleash the potential of precision medicine
In genomics, size really does matter: the larger the dataset, the greater the returns. In the last two decades we have moved from a single genome to datasets of over 100,000. In the next decade datasets of millions will be commonplace. It’s clear, however, that having a big dataset alone is not enough. It is our ability […]
Zetta Genomics and the creation of culture
As a new company surges into existence, it is focused on objectives that turn transformational ideas into a successful business. As Zetta Genomics has attracted the investment and partnerships to scale, our People Team is creating a talent structure that will drive innovation, engineering, productisation, marketing, sales and everything in between. We believe, however, that success depends on another […]
OpenCB: an open-source big data platform for genomic data
Earlier this month, our Software Quality Manager, Pablo Marin-Garcia, was in Vienna for the European Society of Human Genetics’ 2022 conference. In addition to attending some enlightening academic sessions, he also presented a poster on some of the latest developments of OpenCB. What is the OpenCB? Simply put, OpenCB is an open-source software for analysing genomic data, started in 2012 […]
